Evidence map›Paper›PMID 31172217›Full record

ArticleCellular and molecular life sciences : CMLS2019

Regulation of AMPK activity by type 10 adenylyl cyclase: contribution to the mitochondrial biology, cellular redox and energy homeostasis.

Vignesh Jayarajan, Avinash Appukuttan, Muhammad Aslam, Peter Reusch, Vera Regitz-Zagrosek, Yury Ladilov

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Bioactive fraction isolated fromFrontiers in pharmacology · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Vignesh JayarajanCharité, Universitätsmedizin Berlin, Institute of Gender in Medicine, Center for Cardiovascular Research, Berlin, Germany.
Avinash AppukuttanDepartment of Clinical Pharmacology, Ruhr-University Bochum, Bochum, Germany.
Muhammad AslamInternal Medicine I/Cardiology and Angiology, University Hospital of Giessen and Marburg, Giessen, Germany.ORCID https://orcid.org/0000-0002-8529-4217
Peter ReuschDepartment of Clinical Pharmacology, Ruhr-University Bochum, Bochum, Germany.
Vera Regitz-ZagrosekCharité, Universitätsmedizin Berlin, Institute of Gender in Medicine, Center for Cardiovascular Research, Berlin, Germany.
Yury LadilovCharité, Universitätsmedizin Berlin, Institute of Gender in Medicine, Center for Cardiovascular Research, Berlin, Germany. yury.ladilov@rub.de.ORCID http://orcid.org/0000-0002-9836-8801
German Centre for Cardiovascular Research · DERuhr University Bochum · DEJustus-Liebig-Universität Gießen · DE

Funding

Deutsches Zentrum für Herz-Kreislaufforschung 81Z2100201FP7 People: Marie-Curie Actions 2012-ITN
6 · The paper itself

Abstract

The downregulation of AMP-activated protein kinase (AMPK) activity contributes to numerous pathologies. Recent reports suggest that the elevation of cellular cAMP promotes AMPK activity. However, the source of the cAMP pool that controls AMPK activity remains unknown. Mammalian cells possess two cAMP sources: membrane-bound adenylyl cyclase (tmAC) and intracellularly localized, type 10 soluble adenylyl cyclase (sAC). Due to the localization of sAC and AMPK in similar intracellular compartments, we hypothesized that sAC may control AMPK activity. In this study, sAC expression and activity were manipulated in H9C2 cells, adult rat cardiomyocytes or endothelial cells. sAC knockdown depleted the cellular cAMP content and decreased AMPK activity in an EPAC-dependent manner. Functionally, sAC knockdown reduced cellular ATP content, increased mitochondrial ROS formation and led to mitochondrial depolarization. Furthermore, sAC downregulation led to EPAC-dependent mitophagy disturbance, indicated by an increased mitochondrial mass and unaffected mitochondrial biogenesis. Consistently, sAC overexpression or stimulation with bicarbonate significantly increased AMPK activity and cellular ATP content. In contrast, tmAC inhibition or stimulation produced no effect on AMPK activity. Therefore, the sAC-EPAC axis may regulate basal and induced AMPK activity and support mitophagy, cellular energy and redox homeostasis. The study argues for sAC as a potential target in treating pathologies associated with AMPK downregulation.

Indexed as

Adenylyl CyclasesAMP-Activated Protein Kinase KinasesAnimalsCell Physiological PhenomenaCyclic AMPEndothelial CellsEnergy MetabolismGuanine Nucleotide Exchange FactorsHomeostasisHumansMitochondriaMyocytes, CardiacOxidation-ReductionPhosphorylationProtein KinasesRatsAdenylyl CyclasesAMP-Activated Protein Kinase KinasesCyclic AMPGuanine Nucleotide Exchange FactorsProtein KinasesRapgef3 protein, ratADCY10AMPKATPcAMPMitophagyROS

Identifiers

PMID31172217
PMCPMC11105217
OpenAlexW2970416911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.